Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
712
datasets available to search
ShareScore release 0.9.0
Dataset results
712 results for “mantle”
Bortezomib and Lenalidomide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00553644. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell Lymphoma
ClinicalTrials.gov study NCT02633137. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Enzalutamide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT02489123. IPD Sharing: Not stated. Countries: 1. Publications: 0.
INHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With Temsirolimus
ClinicalTrials.gov study NCT01367457. IPD Sharing: Not stated. Countries: 1. Publications: 0.
S1106 Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Patients With Previously Untreated Mantle Cell
ClinicalTrials.gov study NCT01412879. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Abexinostat and Ibrutinib in Diffuse Large B-cell Lymphoma and Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03939182. IPD Sharing: YES. Countries: 1. Publications: 0.
Study to Assess Effect of Oral Venetoclax Tablet in Combination With Oral Ibrutinib Capsule on Best Overall Response of Complete Response in Adult Japanese Participants With Relapsed/Refractory Mantle
ClinicalTrials.gov study NCT04477486. IPD Sharing: YES. Countries: 1. Publications: 0.
Bendamustine Hydrochloride in Combination With Rituximab in Patients With Relapsed Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00891839. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Ofatumumab With or Without Bendamustine for Patients With Mantle Cell Lymphoma Ineligible for Autologous Stem Cell Transplant
ClinicalTrials.gov study NCT01437709. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bendamustine + Obinutuzumab Induction With Obinutuzumab Maintenance in Untreated Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03311126. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 562 in Subjects With r/r Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, or Follicular Lymphoma
ClinicalTrials.gov study NCT03571828. IPD Sharing: YES. Countries: 4. Publications: 0.
A Study of Glofitamab and Lenalidomide in People With Mantle Cell Lymphoma
ClinicalTrials.gov study NCT06192888. IPD Sharing: YES. Countries: 1. Publications: 0.
Bortezomib After Combination Chemotherapy, Rituximab, and an Autologous Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00310037. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bevacizumab + CHOP-Rituximab in Untreated Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00401817. IPD Sharing: Not stated. Countries: 1. Publications: 0.
VELCADE®-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma, or Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00571493. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bortezomib and Vorinostat in Treating Patients With Recurrent Mantle Cell Lymphoma or Recurrent and/or Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT00703664. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma
ClinicalTrials.gov study NCT01180049. IPD Sharing: YES. Countries: 11. Publications: 0.
Safety and Antitumor Activity Study of Loncastuximab Tesirine and Durvalumab in Diffuse Large B-Cell, Mantle Cell, or Follicular Lymphoma
ClinicalTrials.gov study NCT03685344. IPD Sharing: NO. Countries: 2. Publications: 0.
Treatment With Acalabrutinib Post Blood or Marrow Transplantation in Subjects With Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04402138. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Efficacy and Safety of Bortezomib Combined With Fludarabine and Cytarabine Treatment for Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03016988. IPD Sharing: YES. Countries: 0. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.